A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions

Healthy

Interventions

DRUG

ACT-541468

Film-coated tablet for oral use at a dose strength of 50 mg.

DRUG

Zopiclone 7.5 mg

Over-encapsulated to maintain blinding.

OTHER

Placebo

Matching to maintain blinding.

Trial Locations (1)

Centre for Human Drug Research, Leiden